Stelac Advisory Services’s Eli Lilly LLY Stock Holding History

Stelac Advisory Services’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$13.2M	Buy	14,395 +4,129	+40%	+$4.19M	2.67%	11
2025 Q4	$11M	Buy	10,266 +130	+1%	+$124K	3.9%	7
2025 Q3	$7.73M	Sell	10,136 -66	-0.6%	-$49.1K	2.67%	12
2025 Q2	$7.95M	Buy	10,202 +18	+0.2%	+$14K	3.02%	11
2025 Q1	$8.41M	Sell	10,184 -1,127	-10%	-$938K	3.47%	8
2024 Q4	$8.73M	Hold	11,311	–	–	3.4%	9
2024 Q3	$10M	Hold	11,311	–	–	4.06%	8
2024 Q2	$10.2M	Hold	11,311	–	–	4.29%	7
2024 Q1	$8.8M	Buy	+11,311	New	+$8.05M	4.13%	8
2021 Q3	–	Sell	-461	Closed	-$106K	–	247
2021 Q2	$106K	Buy	+461	New	+$92.6K	0.02%	276
2020 Q2	–	Sell	-791	Closed	-$110K	–	148
2020 Q1	$110K	Buy	+791	New	+$109K	0.05%	112
2018 Q3	–	Sell	-2,246	Closed	-$192K	–	160
2018 Q2	$192K	Buy	2,246 +518	+30%	+$42.5K	0.05%	85
2018 Q1	$134K	Buy	+1,728	New	+$139K	0.04%	98
2017 Q2	–	Sell	-8,127	Closed	-$684K	–	72
2017 Q1	$684K	Hold	8,127	–	–	0.21%	31
2016 Q4	$598K	Buy	+8,127	New	+$605K	0.2%	35

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Stelac Advisory Services's LLY Position: Q1 2026 in Review

Stelac Advisory Services increased its Eli Lilly (LLY) stake by 40% in Q1 2026, buying an estimated $4.19M and bringing the position to 14,395 shares worth $13.2M. The position accounts for 2.67% of the portfolio, ranked #11.

Stelac Advisory Services first reported a position in LLY in Q4 2016 and has held it in 15 quarters since. 4,355 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

Stelac Advisory Services held 14,395 shares of Eli Lilly worth $13.2M as of Q1 2026.
Stelac Advisory Services bought 4,129 Eli Lilly shares in Q1 2026, an estimated $4.19M.
Eli Lilly made up 2.67% of Stelac Advisory Services's portfolio in Q1 2026, its #11 holding.
Stelac Advisory Services first reported a position in Eli Lilly in Q4 2016 and has held it in 15 quarters since.
4,355 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Stelac Advisory Services's 13F filing for Q1 2026, filed 8 May 2026.